Nano-graphene oxide composite for in vivo imaging

Int J Nanomedicine. 2018 Jan 3:13:221-234. doi: 10.2147/IJN.S148211. eCollection 2018.

Abstract

Introduction: Positron emission tomography (PET) tracers has the potential to revolutionize cancer imaging and diagnosis. PET tracers offer non-invasive quantitative imaging in biotechnology and biomedical applications, but it requires radioisotopes as radioactive imaging tracers or radiopharmaceuticals.

Method: This paper reports the synthesis of 18F-nGO-PEG by covalently functionalizing PEG with nano-graphene oxide, and its excellent stability in physiological solutions. Using a green synthesis route, nGO is then functionalized with a biocompatible PEG polymer to acquire high stability in PBS and DMEM.

Results and discussion: The radiochemical safety of 18F-nGO-PEG was measured by a reactive oxygen species and cell viability test. The biodistribution of 18F-nGO-PEG could be observed easily by PET, which suggested the significantly high sensitivity tumor uptake of 18F-nGO-PEG and in a tumor bearing CT-26 mouse compared to the control. 18F-nGO-PEG was applied successfully as an efficient radiotracer or drug agent in vivo using PET imaging. This article is expected to assist many researchers in the fabrication of 18F-labeled graphene-based bio-conjugates with high reproducibility for applications in the biomedicine field.

Keywords: graphene oxide; imaging; nanocomposite; radiotracer.

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Fluorine Radioisotopes / chemistry
  • Fluorine Radioisotopes / pharmacokinetics
  • Graphite / chemistry*
  • Graphite / pharmacology
  • Green Chemistry Technology
  • Humans
  • MCF-7 Cells
  • Mice, Nude
  • Nanocomposites / chemistry*
  • Oxides / chemistry
  • Polyethylene Glycols / chemistry
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals / chemistry*
  • Radiopharmaceuticals / pharmacokinetics
  • Reactive Oxygen Species / metabolism
  • Reproducibility of Results
  • Tissue Distribution
  • Xenograft Model Antitumor Assays

Substances

  • Fluorine Radioisotopes
  • Oxides
  • Radiopharmaceuticals
  • Reactive Oxygen Species
  • Polyethylene Glycols
  • Graphite